SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001731122-24-000002
Filing Date
2024-01-03
Accepted
2024-01-03 08:00:32
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM DEFM14A e5304_defm14a.htm DEFM14A 2641931
2 GRAPHIC image_004.jpg GRAPHIC 197460
3 GRAPHIC image_005.jpg GRAPHIC 29410
4 GRAPHIC image_006.jpg GRAPHIC 29143
5 GRAPHIC image_007.jpg GRAPHIC 24137
6 GRAPHIC image_008.jpg GRAPHIC 24451
7 GRAPHIC proxy_001.jpg GRAPHIC 214511
8 GRAPHIC proxy_002.jpg GRAPHIC 712725
  Complete submission text file 0001731122-24-000002.txt   4340584
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFM14A | Act: 34 | File No.: 001-38758 | Film No.: 24504385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)